Effects of ezetimibe on postprandial hyperlipidemia.
Not Applicable
- Conditions
- dyslipidemia
- Registration Number
- JPRN-UMIN000003392
- Lead Sponsor
- Juntendo University School of Medicine, Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)TG > 400mg/dL 2)ATL levels > 2 times the upper limit of normal 3)Serum Cr levels > 3.0mg/dL 4) Patients with secondary hyperlipidemia or drug-associated hyperlipidemia 5)Homozygous familial hypercholesterolemia 6)Patients with a history of unstable angina, MI, CABG or stroke within 3 months of study entry 7) Patients who are pregnant or nursing mothers, patients who may be pregnant, or patients who want to become pregnant during participation in the study. 8) Patients with a history of hypersensitivity to any ingredient of ezetimibe tablets 9) Other patients deemed not appropriate for study entry by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of postprandial liipd levels (TG, apoB48, RLP-C)
- Secondary Outcome Measures
Name Time Method